CCL19 reduces tumour burden in a model of advanced lung cancer

Epstein–Barr virus-induced molecule 1 ligand chemokine (CCL19) is a CC chemokine that chemoattracts both dendritic cells (DC) and T lymphocytes. We evaluated the antitumour efficacy of CCL19 in a murine model of spontaneous bronchoalveolar cell carcinoma. These transgenic mice (CC-10 TAg) express th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hillinger, S, Yang, S-C, Batra, R K, Strieter, R M, Weder, W, Dubinett, S M, Sharma, S
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Translational Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361223/
https://ncbi.nlm.nih.gov/pubmed/16598185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603061
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados